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http://dx.doi.org/10.1016/j.kjms.201Abstract A 44-year-old woman who underwent radical nephrectomy due to a left renal mass
presented to our clinic. Results of the histopathological examination showed a mixed epithelial
and stromal tumor of the kidney, a rare benign lesion of the kidney. The epidemiology, histo-
pathological features, imaging features, possible pathogeneses, and treatment alternatives
are discussed, and the relevant literature is reviewed. The postoperative course was unevent-
ful, and the patient was free of local recurrence or metastasis until the last follow-up (12
months).
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Mixed epithelial and stromal tumor of kidney (MESTK) is
a rare complex renal neoplasm, composed of stromal and
epithelial elements, and a mixture of cystic and solid areas
[1,2]. It was originally described in 1973 by Block et al. as
a congenital mesoblastic nephroma. The term MESTK was
credited to Michal and Syrucek in 1998. Cystic hamartoma
of the renal pelvis, leiomyomatous renal hamartoma, adult
mesoblastic nephroma, multilocular renal cyst with Mu¨lle-
rian-like stroma, and solid and cystic biphasic tumor were
designations for this condition in the past [1,3]. Recent
advances in molecular-level studies of the pathogenesisnt of Urology, West China
Xiang #37, Chengdu, Sichuan
3.com (P. Han).
hsiung Medical University. Publish
2.09.008have resulted in an increased awareness of this type of
renal tumor. In this article, we present a case of MESTK and
a review of the literature.Case report
A 44-year-old Chinese woman presented to our clinic with
flank pain and gross hematuria for 10 days. A physical
examination confirmed the presence of a large fixed,
smooth, elastic, firm mass occupying the left side of the
lower abdomen. Aside from a myomectomy operation 2
years ago, no accompanying disease was present. She was
receiving no medication and had no history of oral contra-
ceptive use. She had not reached menopause, however, and
had long-term irregular menses, algomenorrhea, and spa-
nomenorrhea. All of her laboratory data were within the
normal ranges except for numerous red blood cells and
white blood cells on urinalysis. Abdominal ultrasounded by Elsevier Taiwan LLC. All rights reserved.
Mixed epithelial and stromal tumor 281showed a large cystic mass in the left kidney area. A
computed tomography (CT) scan revealed a well-defined
and unevenly enhanced mass lesion measuring
11.7  7.4 cm in the left kidney (Fig. 1A). Chest X-ray was
negative.
We opted for an open left radical nephrectomy owing to
concerns about cancer and local symptoms, as a result of
the large mass. Gross pathologic examination revealed
a 15  10.5  6 cm, tan to yellow, well-circumscribed, large
lobulated tumor in the renal pelvic cavity and significant
renal parenchyma atrophy (0.2 cm thickness) (Fig. 1B). The
tumor was composed of multiple cysts and solid areas, and
was without necrosis and hemorrhage. Multiple cystic
formations varying from 2 mm to 2 cm could be observed.
Microscopically, the tumor was biphasic comprising
epithelial and stromal elements. It includes microcysts and
tubules, and ovarian-like stroma. The epithelial component
shows flattened cuboidal or hobnail cells (Fig. 2A and B).
The cyst epithelial cells were strongly positive for CK7 and
PCK (Fig. 2C and D).The stromal elements displayed CD10
(þ), Desmin (þ), ER (þ), Vimentin (þ), and PR (þ)
(Fig. 2EeI). None expressed CD34, S-100, HMB-45, CD99, or
inhibin. The PAS stain was negative.
The final histopathological diagnosis was MESTK. The
vascular, ureteral, renal pelvis, and capsular surgical
margins were intact. The postoperative course was
uneventful, and the patient was free of local recurrence or
metastasis until the last follow-up (12 months).Figure 1. Abdominal computed tomography revealed an
11.7  7.4 cm unevenly enhanced mass (A, white arrow: the
exophytic multiseptate cystic mass with solid component).
(B) Gross picture of the surgical specimen.Discussion
MESTK is a distinct category of renal neoplasm. Patients’
ages range from 19 to 84 years (mean, 46 years), with
a female/male incidence ratio of 10-6:1. It often affects
women with prolonged estrogen exposure and rarely occurs
in male patients who have undergone androgen deprivation
therapy. Most patients typically present with flank pain,
a palpable abdominal or flank mass, hematuria, or symp-
toms related to genitourinary infections, although up to
25% of tumors are identified incidentally [1,2,4,5].
MESTK is typically a centrally located, tan to yellow,
well-circumscribed, solid cystic lesion, with 1.7e20 cm
being the largest. In this case, owing to loss of the perirenal
fascia tension, a CT scan showed that the surgical specimen
was larger than the size of the mass. Microscopically, the
MESTK contained an admixture of stroma and epithelial
lined large cysts, microcysts, and tubules. In general, ER,
PR, CD10, Vimentin, Desmin, SMA, and inhibin expression
was seen in the stromal component. HMB-45, S-100, CD99,
CD117, and CD34 stains were negative. The epithelial
components were positive for CK7, PCK, cytokeratin AE1/3,
Ulex europaeus, and calretinin [1,2,5,6].
MESTKs have certain features in imaging and are more
common in Bosniak III/IV. Most MESTKs can be described as
well circumscribed in the renal pelvis or protruding from
the cortex, and show multiseptate cystic renal masses with
thick septa and solid components. The emphasis here is on
enhancing the image of the solid components with the
delayed enhancement during the nephrographic phase in
the contrast-enhanced CT images. The different extent of
the delayed enhancement may depend on the spindle cell
components of these masses, which exhibit variable
patterns and cellularity ranging from paucicellular fibrosis
to densely cellular areas [7,8].
However, the pathogenesis of MESTK is still not clear.
There are several theories to explain the possible histo-
genesis mechanism. One hypothesis is the presence of
multidifferentiation potential fetal primitive mesenchyme
or metanephric blastema in the kidney, which may be an
epithelialestromal interaction given its status of hormonal
hyperstimulation, which may then cause the proliferation
to form a mass [3,9]. Another hypothesis is the abnormal
migration of ovarian stromal cells during embryogenesis.
Because of the close proximity of mesonephric ducts and
Mu¨llerian ducts during the 4th week of development,
ovarian stromal cells could become incorporated in the
ureteric bud and metanephric mesoderm. These cells may
become activated in the steroid hormonal stimulation,
secrete paracrine factors, and induce proliferation of the
adjacent epithelium [3]. Above all, although the histogen-
esis of MESTK is unknown, in view of the frequent expres-
sion of ER and PR in the stromal component and the
existence of ovarian-type stroma, both theories suggest
that the steroid hormones might play a role in the evolution
of these tumors.
Tickoo et al. [10] believed that ER/PR-positive stromal
proliferation can be present in some nonneoplastic kidneys
and the part of neoplastic kidneys away from the tumor,
such as ureterepelvic junction stenosis, benign multi-
locular cyst, benign ureteric stricture, acquired cystic
Figure 2. Histopathologically, microcysts and tubules and ovarian-like stroma (A, hematoxylin and eosin, 100); cysts lined with
flattened cuboidal or hobnail epithelium (B, hematoxylin and eosin, 200). Immunohistochemically, the epithelial cells are focally
positive for CK7 (C, 400), PCK (D, 400); and the stromal cells are positive for CD10 (E, 400), DES (F, 400), ER (G, 400), VIM
(H, 400), and PR (I, 400).
282 S. Zheng et al.disease-associated renal cell carcinoma (RCC), urothelial
carcinoma ureter, urothelial carcinoma bladder, chromo-
phobe RCC, clear cell RCC, except for MEST and cystic
nephroma. However, they observed that the diseases
mentioned above had a common findingda generalized or
segmental hydronephrosis, or tumor compression-related
focal obstruction. Based on this finding, they reached
a conclusion that renal obstructive changes may represent
a metaplastic change in the renal interstitial cells
surrounding these obstructed epithelial structures. More-
over, the ER/PR stoma seen in association with renal tumors
may also be a secondary (metaplastic) response to their
cystic epithelial components and not necessarily
a neoplastic constituent. Similarly, using electron micros-
copy, Picken and Fresco [11] found that the tubules in
MESTK are entrapped rather than neoplastic. To summa-
rize, we postulate that the histogenesis of MEST results not
only from the stimulation of the hormones, which cause the
proliferation to form a mass, but also that the cysts’
compression-related obstructive changes may likewise play
an important role in its development. Through a synergistic
action, the MESTK may grow larger and lead to further
clinical symptoms. We argue that this requires further
study.
Tumor spillageor positive surgicalmargins arepresumably
risk factors for local recurrence [12]. Hence, complete
surgical resection is the preferred treatment for MESTK.
According to the patient’s condition, partial or complete
nephrectomy was chosen. And when a partial nephrectomy
was performed to exclude a posyitive margin, anintraoperative frozen section was helpful [2]. Because the
tumor was rare and the preoperative diagnosis was difficult,
we could not rule out malignancy. At this point, the treat-
ment of choice was nephrectomy and the complete removal
of the tumor. For the diagnosis, preoperative biopsy may
cause the cyst to rupture and increase the risk of recurrence.
Therefore, preoperative biopsy should be conservative. In
terms of clinical behavior, rare aggressive behavior has been
reported [13]; however,most cases ofMESTKexhibit a benign
histologic picture and clinical course, and both neoplasms
are benign and surgical excision results in restoration [1]. If
diagnosed preoperatively, for the patient who has a high risk
for an operation, follow-up without any operation might be
an alternative.
In conclusion, MESTK is relatively rare, and when based
only on imaging, it is difficult to distinguish between benign
or malignant tumors. Therefore, pathogenesis and preop-
erative diagnosis should be further explored.Acknowledgments
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